Original Article
Neuropsychopharmacology (2005) 30, 417–422, advance online publication, 3 November 2004; doi:10.1038/sj.npp.1300598
Clinical Research
Increased Attributable Risk Related to a Functional
-Opioid Receptor Gene Polymorphism in Association with Alcohol Dependence in Central Sweden
Gavin Bart1, Mary Jeanne Kreek1,2, Jurg Ott3, K Steven LaForge1, Dmitri Proudnikov1, Lotta Pollak2 and Markus Heilig2,4
- 1The Laboratory of the Biology of Addictive Diseases, The Rockefeller University, New York, NY, USA
- 2Karolinska Institute, Stockholm, Sweden
- 3The Laboratory of Statistical Genetics, The Rockefeller University, New York, NY, USA
- 4Laboratory of Clinical Science, NIAAA, NIH, Bethesda MD, USA
Correspondence: Dr G Bart, The Laboratory of the Biology of Addictive Diseases, The Rockefeller University, 1230 York Avenue, New York, NY 10021, USA. Tel: +212 327 8282; Fax: +212 327 7023; E-mail: bartg@rockefeller.edu
Received 28 June 2004; Revised 24 August 2004; Accepted 22 September 2004; Published online 3 November 2004.
Abstract
The
-opioid receptor (MOR), through its effects on reward and stress-responsivity, modulates alcohol intake in both animal and human laboratory studies. We have previously demonstrated that the frequently occurring A118G single-nucleotide polymorphism (SNP) in exon 1 of the MORgene (OPRM1), which encodes an amino-acid substitution, is functional and receptors encoded by the variant 118G allele bind the endogenous opioid peptide
-endorphin with three-fold greater affinity than prototype receptors. Other groups subsequently reported that this variant alters stress-responsivity in normal volunteers and also increases the therapeutic response to naltrexone (a
-preferring opioid antagonist) in the treatment of alcohol dependence. We compared frequencies of genotypes containing an 118G allele in 389 alcohol-dependent individuals and 170 population-based controls without drug or alcohol abuse or dependence. The A118G SNP was present in the Hardy–Weinberg equilibrium with an overall frequency of the 118G allele of 10.9%. There was a significant overall association between genotypes with an 118G allele and alcohol dependence (p=0.0074). The attributable risk for alcohol dependence in subjects with an 118G allele was 11.1%. There was no difference in A118G genotype between type 1 and type 2 alcoholics. In central Sweden, the functional variant 118G allele in exon 1 of OPRM1 is associated with an increased attributable risk for alcohol dependence.
Keywords:
alcohol dependence, single-nucleotide polymorphism, opioid system, endogenous, association study, opioid receptor
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
NEWS AND VIEWS
Nature Medicine News and Views (01 Jan 2005)
Nature News and Views (31 Oct 1996)
RESEARCH
Neuropsychopharmacology Original Article
The Mu-Opioid Receptor Polymorphism A118G Predicts Cortisol Responses to Naloxone and Stress
Neuropsychopharmacology Original Article

